amprenavir

(redirected from 141W94)
Also found in: Medical.
Translations

amprenavir

n amprenavir m
References in periodicals archive ?
HIV Drugs 1999 Nonnucleoside Nucleoside Reverse Reverse Transcriptase Transcriptase Inhibitors Inhibitors (NNRTI) (NRTI) Rescriptor Combivir (delavirdine mesylate) (lamivudine/zidovudine) Viramune Epivir (nevirapine) (lamivudine) Sustiva Retrovir (efavirenz; DMP-266) (zidovudine; AZT; ZDV) Zerit (stavudine; d4T) Hivid (zalcitabine; ddC) Videx (didanosine; ddl) Ziagan (abacavir; 1592) Nucleotide Analogue Protease Inhibitors (PI) (*)Preveon Crixivan (adefovir dipivoxil; PMEA) (indinavir) Norvir (ritonavir) Fortovase (saquinavir) Viracept (nelfinavir mesylate) (*) Agenerase[TM] (amprenavir; 141W94, VX-478)
Agenerase (amprenavir; formerly 141W94, VX - 478) is a new protease inhibitor drug from Vertex and Glaxo Wellcome in Phase III clinical trials.